Advanced Precision in Ocular Biometry
The ZEISS IOLMaster 500 is a state-of-the-art optical biometer designed to provide highly precise and reproducible measurements. Its accuracy aligns seamlessly with manual keratometry while surpassing it in precision. By integrating a diverse range of validated formulas, this device ensures reliable refractive outcomes, offering confidence in every calculation.
User-Friendly Interface and Optimized Workflow
Engineered for efficiency, the ZEISS IOLMaster 500 features an intuitive user interface, logical plausibility checks, and distance-independent measurement capabilities. Compared to conventional optical biometers, it operates up to four times faster, allowing for a complete bilateral eye assessment in under 60 seconds. This streamlined workflow enhances patient throughput, benefiting both the medical team and the patients.
Enhanced Performance in Dense Cataracts
In cases of advanced cataracts, this biometer outperforms others with a 20% higher success rate in obtaining accurate measurements. With an impressive 93% penetration rate, it remains effective even in challenging conditions, such as staphyloma, pseudophakic eyes, and silicone-filled eyes. Additionally, the Haigis-L formula incorporated in the system ensures precise intraocular lens (IOL) calculations for patients with a history of laser vision correction (LVC).
Seamless Integration for Cataract Surgery
As an essential component of the ZEISS Cataract Suite, this device captures a high-resolution reference image for intraoperative alignment. By matching preoperative and real-time surgical images, the need for manual corneal marking is eliminated. This not only increases efficiency but also enhances the accuracy of toric IOL alignment, minimizing residual astigmatism for improved postoperative visual outcomes.
Worldwide Shipping Available
We offer professional packaging and global shipping for the ZEISS IOLMaster 500 at an additional cost. Contact us for more details on delivery options and pricing.
There are no reviews yet.